The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(benzylamino)-4-hydroxypyrimidine-5-carbonyl)glycine ID: ALA5220475
Chembl Id: CHEMBL5220475
PubChem CID: 168298147
Max Phase: Preclinical
Molecular Formula: C14H14N4O4
Molecular Weight: 302.29
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CNC(=O)c1cnc(NCc2ccccc2)nc1O
Standard InChI: InChI=1S/C14H14N4O4/c19-11(20)8-15-12(21)10-7-17-14(18-13(10)22)16-6-9-4-2-1-3-5-9/h1-5,7H,6,8H2,(H,15,21)(H,19,20)(H2,16,17,18,22)
Standard InChI Key: NQMYTFWVTKAQJA-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 302.29Molecular Weight (Monoisotopic): 302.1015AlogP: 0.61#Rotatable Bonds: 6Polar Surface Area: 124.44Molecular Species: ACIDHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.67CX Basic pKa: 1.89CX LogP: 1.03CX LogD: -2.09Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.62Np Likeness Score: -1.26
References 1. Zhi S, Cai J, Wang H, Tan C, Yang Z, Dai L, Zhang T, Wang H, Li D.. (2022) Synthesis and biological evaluation of (4-hydroxy-2-(substitued sulfonamido)pyrimidine-5-carbonyl)glycines as oral erythropoietin secretagogues., 76 [PMID:36174835 ] [10.1016/j.bmcl.2022.129007 ]